Magnetic Nanoparticles as Contrast Agents for MR Imaging
Published 1 January 1997
Jeff W. M. Bulte, Rodney A. Brooks
Citations33
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This chapter presents an overview of the use of magnetic nanoparticles as contrast agents for MRI, and covers the basic principles of preparation and characterization, including variable-field relaxometry.
Abstract
Following a brief introduction to the basic concepts of relaxation and contrast enhancement in magnetic resonance imaging (MRI), this chapter presents an overview of the use of magnetic nanoparticles as contrast agents for MRI. It covers the basic principles of preparation and characterization, including variable-field relaxometry. It is shown how a detailed understanding of Ti and T2 relaxation by magnetic nanoparticles may aid further magnetopharmaceutical development. While this overview is far from complete because of the rapid recent developments in the field, an attempt is made to give an overview of current applications and future directions of magnetic nanoparticles as MR contrast agent.
Keywords
ChemistryMedicineEngineering
The Journal of Chemical PhysicsProton Relaxation Times in Paramagnetic Solutions
1,046 Citations1957N. Bloembergen
RadiologyUltrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
1,020 Citations1990Ralph Weissleder, G Elizondo +4 more
An ultrasmall superparamagnetic iron oxide preparation was developed that is small enough to migrate across the capillary wall, a prerequisite in the design of targetable particulate pharmaceuticals.
Magnetic Resonance ImagingPhysical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil
615 Citations1995Chu W. Jung, Paula Jacobs
The bulk physiochemical properties of the active ingredients in three AMI colloidal, superparamagnetic iron oxide (SPIO), MR contrast agents are described and ferrous content and X-Ray diffraction of the colloids are consistent with nonstoichiometric magnetite phases in all three active ingredients.
Journal of Immunological MethodsImmunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells
611 Citations1982Robert S. Molday, Donald J. MacKenzie
These novel reagents were used to indirectly label antigen sites on human red blood cells and thymocytes for visualization by scanning and transmission electron microscopy and could be separated from unlabeled cells.
The Journal of Chemical PhysicsDynamic effects of pair correlation functions on spin relaxation by translational diffusion in liquids
599 Citations1975Lian‐Pin Hwang, Jack H. Freed
ScienceMagnetoferritin: in Vitro Synthesis of a Novel Magnetic Protein
571 Citations1992Fiona C. Meldrum, Brigid R. Heywood +1 more
Transmission electron microscopy and electron diffraction analysis indicate that the entrapped mineral particles are discrete 6-nanometer spherical single crystals of the ferrimagnetic iron oxide magnetite (Fe3O4).
RadiologySuperparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
514 Citations1988David D. Stark, Ralph Weissleder +6 more
These initial clinical results appear to confirm extensive preclinical data indicating that ferrite administered at a dose of 20 mumol/kg has the potential to significantly improve the performance of abdominal MR imaging.
Magnetic Resonance in MedicineMonocrystalline iron oxide nanocompounds (MION): Physicochemical properties
501 Citations1993Tueng T. Shen, Ralph Weissleder +3 more
The physicochemical properties of MION are reported using a variety of analytical techniques to show that a novel monocrystalline iron oxide nanocompound, a stable colloid that enables target specific MR imaging, has an inverse spinel crystal structure.
NatureSynthesis of inorganic nanophase materials in supramolecular protein cages
464 Citations1991Fiona C. Meldrum, Vanessa J. Wade +3 more
The Journal of Chemical PhysicsDynamic effects of pair correlation functions on spin relaxation by translational diffusion in liquids. II. Finite jumps and independent <i>T</i>1 processes
438 Citations1978Jack H. Freed
Advanced Drug Delivery ReviewsLong-circulating iron oxides for MR imaging
397 Citations1995Ralph Weissleder, Alexei Bogdanov +2 more
Magnetic Resonance in MedicineTransverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite
353 Citations1987Pierre Gillis, Seymour H. Koenig
On the basis of the agreement of theory with data for solutions of small paramagnetic complexes, large magnetite particles, and liver containing low‐density polymer‐coated magnetite agglomerates, it is argued that the theory is sufficiently reliable so that, e.g., for ferritin, it appears that diffusion through intracellular gradients determines 1/T2.
Journal of Magnetic Resonance (1969)Nuclear relaxation in macromolecules by paramagnetic ions: a novel mechanism
325 Citations1975M. Guéron
Magnetic Resonance in MedicineTheory of 1/<i>T</i><sub>1</sub> and 1/<i>T</i><sub>2</sub> NMRD profiles of solutions of magnetic nanoparticles
313 Citations1995Seymour H. Koenig, Kenneth E. Kellar
The authors have reformulated outer sphere relaxation theory to incorporate progressive magnetic saturation of solute nanoparticles and indicate how to use empirical magnetization data for realistic particles when their magnetic properties are not ideal.
ScienceSynthesis and Structure of an Iron(III) Sulfide-Ferritin Bioinorganic Nanocomposite
275 Citations1995Trevor Douglas, D.P.E. Dickson +4 more
The approach used here for the controlled synthesis of bioinorganic nanocomposites could be useful for the nanoscale engineering of dispersed materials with biocompatible and bioactive properties.
ScienceClassical and Quantum Magnetic Phenomena in Natural and Artificial Ferritin Proteins
242 Citations1995S. Gider, D. D. Awschalom +3 more
At high magnetic fields, a spin flop transition with a strong dependence on orientation was seen in the natural ferritin, providing evidence of antiferromagnetism in this system.
European Biophysics JournalMagnetoliposomes
239 Citations1988Marcel De Cuyper, Marcel Joniau
The adsorption of different types of phosphatidylglycerols onto magnetizable solid particles is studied to establish the bilayer character of the phospholipid coat and the affinity constants, derived from them, progressively increase as the hydrophobic nature of the phosphorus-based particles is more pronounced.
Magnetic Resonance ImagingThe effects of iron oxides on proton relaxivity
219 Citations1988Lee Josephson, J. Lewis +3 more
The magnetic properties and relaxivities of superparamagnetic, ferromagnetic and paramagnetic iron oxides are presented and compared and Superparamagnetic colloids of larger solution particle size have a lower spin-lattice relaxivity than colloids comprised of smaller solution particle sizes.
Magnetic Resonance in MedicineIntracellular labeling of T‐cells with superparamagnetic contrast agents
199 Citations1993Tzu‐Chen Yeh, Weiguo Zhang +2 more
The results suggest that intracellular labeling of specific cell types can be achieved with good efficiency and the labeled cells can be detected by magnetic resonance imaging in rat testicles in vivo.
Journal of Magnetic Resonance ImagingPhase I clinical evaluation of a new iron oxide MR contrast agent
196 Citations1994Stuart J. McLachlan, Marie R. Morris +6 more
The safety and magnetic resonance (MR) imaging potential of BMS 180549, a new superparamagnetic iron oxide contrast agent, were evaluated in a phase I, open‐label, placebo‐controlled study involving 41 healthy subjects.
Bulletin of the Chemical Society of JapanConditions for the Formation of Fe3O4 by the Air Oxidation of Fe(OH)2 Suspensions.
190 Citations1974Masao Kiyama
RadiologyAntimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging.
186 Citations1992Ralph Weissleder, A S Lee +3 more
The results indicate the feasibility of immunospecific MR imaging in living organisms and confirm the specific binding of the immunoconjugate to infarcted, but not to normal, myocardium.
Magnetic Resonance in Medicine<i>In Vivo</i> Dynamic MRI Tracking of Rat T‐Cells Labeled with Superparamagnetic Iron‐Oxide Particles
171 Citations1995Tzu‐Chen Yeh, Weiguo Zhang +2 more
These results represent the first successful demonstration of dynamic tracking of specific cells in vivo using MRI and significantly enhances the sensitivity for detection of superparamagnetically labeled T‐cells.
Journal of Magnetic Resonance ImagingMagnetoferritin: Characterization of a novel superparamagnetic MR contrast agent
162 Citations1994Jeff W. M. Bulte, Trevor Douglas +8 more
With its nanodimensional biomimetic protein cage as a rigid, convenient matrix for complexing a plethora of bioactive substances, magnetoferritin may provide a novel template for specific targeting of selected cellular sites.
Magnetic Resonance in MedicineTargeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells <i>in Vivo</i> by using transferrin receptor pathways
160 Citations1998Mayk Kresse, Susanne Wagner +4 more
The results demonstrate that a combination of the USPIO relaxivity properties with the specificity of transferrin‐medi‐ated endocytosis allows in vivo detection of tumors by MR imaging.
Bioconjugate ChemistryAntibody-magnetite nanoparticles: In vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging
153 Citations1993Louis Tiefenauer, G. Kuehne +1 more
The preparation and in vitro characterization of tumor-specific superparamagnetic particles (SMP) are described and the polypeptide coat chosen provides an ideal platform for the attachment of biological modifiers needed for the reduction of the antigenicity and blood clearance rate of anti-CEA SMP.
RadiologyPolyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
151 Citations1991Ralph Weissleder, A S Lee +6 more
Results indicate that antibody MR imaging is feasible in vivo and could be easily extended to other applications, including detection of cancer, infarction, and degenerative diseases.
Magnetic Resonance ImagingIn vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI
150 Citations1996Louis Tiefenauer, A. Tschirky +2 more
The usefulness of nanoparticles as image contrast agents is probably limited by their microdistribution within the tumor tissue, and the requirements for a contrast agent to be highly tissue specific are discussed.
Magnetic Resonance in MedicineSpecific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles
147 Citations1992Jeff W. M. Bulte, Yke Hoekstra +9 more
Human lymphocytes were labeled with biotinylated anti‐lymphocyte‐directed monoclonal antibodies, to which streptavidin and subsequently dextran‐magnetite particles were coupled, resulting in a strong and selective negative contrast enhancement of lymphocyte suspensions at 2.0 T.
NeurosurgeryDelivery of Virus-sized Iron Oxide Particles to Rodent CNS Neurons
138 Citations1994Edward A. Neuwelt, Ralph Weissleder +10 more
To examine the delivery of virus-sized particles across the blood-brain barrier (BBB), dextran coated, superparamagnetic monocrystalline iron oxide particles were delivered to rat brain by direct intracerebral inoculation or by osmotic BBB disruption with hypertonic mannitol.
Magnetic Resonance in MedicineSelective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles
137 Citations1993Jeff W. M. Bulte, D. Loralie +6 more
The labeling of PBMCs presented here may be used in future studies of selective MR imaging of in vivo cell migration in a variety of immunologically compromised tissue states, e.g., tumors, transplantations, and abscesses.
RadiologyMR imaging of phagocytosis in experimental gliomas.
124 Citations1995Claus Zimmer, Ralph Weissleder +4 more
Phagocytosis of glioma cells can be detected in vivo with iron oxide-enhanced MR imaging, and this may permit accurate delineation of tumor margins.
PubMedMR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
123 Citations1996Laura G. Remsen, Christopher McCormick +7 more
Monoclonal antibodies conjugated with monocrystalline iron oxide particles may provide a method to obtain specific diagnoses with the use of MR imaging.
PubMedComparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.
123 Citations1995Leslie L. Muldoon, Gajanan Nilaver +7 more
In a preliminary test of vector delivery in the feline, MION was detected throughout the white matter tracts after inoculation into normal cat brain, suggesting MION may be a tool for use in vivo, to monitor the delivery of virus to the central nervous system.
Proceedings of the National Academy of SciencesUranium-loaded apoferritin with antibodies attached: molecular design for uranium neutron-capture therapy.
122 Citations1992J. F. Hainfeld
A method is described to deliver 235U to tumors; the isotope would then be fissioned by incident neutrons, producing localized lethal radiation sufficient for therapy.
NeurosurgeryIncreasing Volume of Distribution to the Brain with Interstitial Infusion: Dose, Rather Than Convection, Might Be the Most Important Factor
114 Citations1996Robert A. Kroll, Michael A. Pagel +3 more
Dose, rather than convection, might be the most important variable in maximizing the Vt and improved distribution might be achieved by administering an increased concentration of agent.
Magnetic Resonance in MedicineT1 and t2 of ferritin at different field strengths: effect on mri
112 Citations1992Josef Vymazal, Rodney A. Brooks +4 more
T1 was relatively constant, but 1/T2 increased linearly with field strength, in agreement with earlier MRI observations in the monkey brain, and supports the theory that ferritin is responsible for T2 shortening in brain nuclei containing iron.
Journal of Magnetic Resonance ImagingFrequency dependence of MR relaxation times II. Iron oxides
111 Citations1993Jeff W. M. Bulte, Josef Vymazal +3 more
Magnetic Resonance in MedicineMonoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
97 Citations1989Sebastián Cerdán, Hans Ruedi Lötscher +2 more
A highly specific and powerful magnetic resonance imaging contrast agent has been prepared by coating magnetite (Fe3 O4) particles with monoclonal antibodies directed against a tumor antigen.
RadiologyReceptor imaging: application to MR imaging of liver cancer.
91 Citations1990Peter Reimer, Ralph Weissleder +3 more
In vitro relaxation and in vivo MR imaging experiments of liver tumors show that targeting USPIO to hepatocytes rather than to the mononuclear phagocytic system allows a considerable dose reduction, increases tumor-liver contrast, and potentially allows distinction of ASG-positive (benign hepatocellular) and AsG-negative (malignant hepato cellular) tumors.
Magnetic Resonance ImagingA functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent
88 Citations1990Lee Josephson, Ernest Groman +3 more
A surface functionalized superparamagnetic iron oxide colloid whose clearance from the vascular compartment was inhibited by asialofetuin but not fetuin is synthesized and may be the basis of MR contrast agents internalized by receptor mediated endocytosis generally, and by the asialoglycoprotein receptor in particular.
Experimental NeurologyNuclear Magnetic Resonance (NMR) Imaging of Iron Oxide-Labeled Neural Transplants
86 Citations1993Nicholas Hawrylak, Pratik Ghosh +4 more
The NMR images and immunohistochemical and histochemical staining of hosts containing labeled cells suggest cell migration of astrocytes and macrophages up to 2 mm away from the graft sites suggest cell survival and migration following neural grafting procedures.
Magnetic Resonance in Medicine<i>T</i><sub>1</sub> and <i>T</i><sub>2</sub> of ferritin solutions: Effect of loading factor
83 Citations1996Josef Vymazal, Olga Zak +3 more
The results may help in the use of MRI to measure brain iron and possibly even ferritin loading factor, and a contribution from a small number of iron ions bound to the protein shell is indicated.
Journal of Magnetic Resonance (1969)Dextran-magnetite: A new relaxation reagent and its application to T2 measurements in gel systems
82 Citations1978Mikio Ohgushi, Kuniaki Nagayama +1 more
Proceedings of the National Academy of SciencesIron—dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy
72 Citations1979Anne H. Dutton, K. T. Tokuyasu +1 more
Transmission electron microscopic experiments with the Imposil-antibody conjugates demonstrate their suitability as specific immunostains at high resolution, particularly for simultaneous double staining experiments in conjunction with ferritin-antibia conjugate conjugacy.
Human Gene TherapySelective Uptake of Viral and Monocrystalline Particles Delivered Intra-Arterially to Experimental Brain Neoplasms
69 Citations1995Nikolai G. Rainov, Claus Zimmer +5 more
Biochimica et Biophysica Acta (BBA) - BiomembranesTrapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes
65 Citations1994Alexei Bogdanov, Christopher Martin +2 more
The accessibility of liposomal PE for acylation was demonstrated by modification with an activated ester of methoxy poly(ethylene glycol) succinate, and an increase of relative PE-content in extracts ofliposomes incubated at lowered pH was detected.
Magnetic Resonance ImagingImmunospecific NMR contrast agents
64 Citations1986Perry F. Renshaw, Charles S. Owen +2 more
The use of macromolecular ferromagnetic and superparamagnetic particles provides, for the first time, an NMR relaxation agent that is effective at subnanomolar concentrations.
Magnetic Resonance ImagingMion-ASF: Biokinetics of an MR receptor agent
61 Citations1993Bradley K. Schaffer, Carey Linker +7 more
Competition assays indicate that receptor-mediated hepatocyte uptake can be competitively blocked and that this effect can be demonstrated by imaging, and indicate that sensitive iron oxide based probes can be developed for functional MR imaging.
Brain ResearchMagnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent
59 Citations1992Andrew B. Norman, Stephen R. Thomas +3 more
Rat fetal brain tissue was incubated in vitro with superparamagnetic ferrite particles covalently coupled to the lectin wheat germ agglutinin (WGA) and transplanted into the adult rat striatum and Histological analysis revealed that theferrite particles were largely restricted to the transplant in a patchy distribution.
RadiologyPancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging.
54 Citations1994Peter Reimer, Ralph Weissleder +3 more
Target-specific MR imaging of pancreatic receptors is feasible and additional studies are necessary to perfect binding strategies, optimize preparations, and scale up synthesis for imaging in other species.
Bioconjugate ChemistryMagnetically Labeled Secretin Retains Receptor Affinity to Pancreas Acinar Cells
53 Citations1996Tueng T. Shen, Alexei Bogdanov +4 more
The data indicate that bioactive peptides can be attached to dextran-coated iron oxide particles through the biotin-streptavidin interaction while retaining receptor affinity.
Magnetic Resonance in MedicineDextran‐magnetite particles: Contrast‐enhanced MRI of blood–brain barrier disruption in a rat model
45 Citations1992Jeff W. M. Bulte, M. W. A. Jonge +7 more
Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast.
Investigative RadiologyMagnetoferritin
40 Citations1994Jeff W. M. Bulte, Trevor Douglas +7 more
Magnetoferritin: biomineralization as a novel molecular approach in the design of iron-oxide-based magnetic resonance contrast agents.
PubMedMagnetoferritin. Biomineralization as a novel molecular approach in the design of iron-oxide-based magnetic resonance contrast agents.
40 Citations1994Jeff W. M. Bulte, Trevor Douglas +7 more
Magnetic Resonance in MedicineDextran magnetite as a liver contrast agent
39 Citations1991Richard L. Magin, G. Bacic +4 more
The results demonstrate that the MRI contrast enhancement observed with dextran magnetite is based on its selective uptake and distribution in the macrophages in the liver and spleen and that this agent has substantial potential as a superparamagnetic MR contrast agent.
Academic RadiologyInitial assessment of magnetoferritin biokinetics and proton relaxation enhancement in rats
32 Citations1995Jeff W. M. Bulte, Trevor Douglas +4 more
In the rat, equine magnetferritin is rapidly sequestered by cells of the reticuloendothelial system, with no direct involvement of ferritin receptors, which may allow the use of magnetoferritin as an MR contrast agent for the liver and spleen.
RadiologyDeterminants of in vivo MR imaging of slow axonal transport.
31 Citations1994K.J. van Everdingen, W S Enochs +6 more
Those characteristics of MION-based contrast agents that promote efficacy after intraneural injection may impede delivery to the nerve after intraarterial injection.
Experimental NeurologyMR Imaging of Slow Axonal Transport in Vivo
30 Citations1993W S Enochs, B. Schaffer +6 more
MION-based magnetopharmaceuticals can be used to demonstrate slow axonal transport, and thereby visualize peripheral nerves, in vivo by MR imaging, and are consistent with the mechanism of slow transport.
RadiologyCerebral iron oxide distribution: in vivo mapping with MR imaging.
29 Citations1995Claus Zimmer, Ralph Weissleder +4 more
MR imaging is well suited to noninvasive in vivo mapping of the intracerebral iron oxide distribution of the central nervous system with in vivo magnetic resonance (MR) imaging.
HepatologyUse of An Asialoglycoprotein Receptor–Targeted Magnetic Resonance Contrast Agent to Study Changes in Receptor Biology During Liver Regeneration and Endotoxemia in Rats
23 Citations1996C Leveille-Webster, James Rogers +1 more
The value of BMS 180550 is documented in following changes in ASGP function that accompany PH or systemic endotoxemia, and the dose of contrast agent needed to cause a deviation from first‐order kinetics increased, suggesting gradual recovery of ASGP receptor function.
Journal of Magnetic Resonance ImagingAxonal transport and MR imaging: Prospects for contrast agent development
22 Citations1994Aaron G. Filler
Recently a number of investigators have reported preliminary success in developing intraneural contrast agents based on various versions of dextran‐coated magnetite that may render magnetic resonance imaging capable of depicting axonal transport.
Hyperfine InteractionsMössbauer spectroscopic and magnetic studies of magnetoferritin
22 Citations1994Quentin A. Pankhurst, S. Betteridge +4 more
Antimicrobial Agents and ChemotherapyQuantitation of slow drug release from an implantable and degradable gentamicin conjugate by in vivo magnetic resonance imaging
19 Citations1995Ralph Weissleder, Kirtland Poss +3 more
Hydrogel implants into rats resulted in a prolonged release of gentamicin and a decreased 24-h mortality in mice infected with a lethal dose of Pseudomonas aeruginosa, indicating the feasibility of imaging and quantitating therapeutic drug concentrations in vivo by MRI.
Acta Oto-LaryngologicaMR Imaging of Neuronal Transport in the Guinea Pig Facial Nerve: Initial Findings
17 Citations1995A. E. Petropoulos, B. Schaffer +4 more
Results show that MION-based magnetopharmaceuticals can be used to demonstrate slow axonal transport, and thereby visualize functional peripheral nerves in vivo by MR imaging, and holds promise for developmental neuroscience research.
Magnetic Resonance ImagingThe use of magnetic resonance imaging to track controlled drug release and transport in the brain
16 Citations1993Brad Reisfeld, Stephen J. Blackband +4 more
A method has been developed to track controlled drug release and transport in the brain through the use of a polymeric implant to release, over time, a paramagnetically labelled compound into the brain.
Investigative RadiologyRecent Developments in Design, Characterization, and Understanding of MRI and MRS Contrast Media
15 Citations1990Robert N. Müller, Patrick Vallet +8 more
Magnetite as a Potent Contrast-Enhancing Agent in Magnetic Resonance Imaging to Visualize Blood-Brain Barrier Disruption
12 Citations1993Jeff W. M. Bulte, M. W. A. Jonge +5 more
The present findings demonstrate the usefulness of DMP for contrast enhancement of lesions following disruption of the blood-brain barrier.
Passage of DMP Across a Disrupted BBB in the Context of Antibody-mediated MR Imaging of Brain Metastases
8 Citations1990Jeff W. M. Bulte, M. W. A. Jonge +6 more
Both components of these conjugates were tested for their ability to penetrate the endothelium during conditions of local blood-brain barrier (BBB) impairment and it was found that passage across endothelial cell occurred in the tumor within four hours after injection.
Investigative RadiologyA Drug System (PDH) for Interventional Radiology Synthesis, Properties, and Efficacy
6 Citations1993Ralph Weissleder, Alexei Bogdanov +6 more
PDH and its derivatives are relatively nontoxic, biodegradable materials for use in radiologic interventions and as a vehicle for sustained drug release.
PubMed[Presentation and quantification of acute myocardial infarct using antibody-bound MR contrast medium].
4 Citations1995H. Frank, Ralph Weissleder +1 more
The results are evidence that a) immunospecific magnetic probes can be utilized for cardiac MR imaging, and b) that these or similar agents may aid in the quantitation of myocardial infarct size.
…